Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 14 | Starlite/ChEMBL | References |
Homo sapiens | discoidin domain receptor tyrosine kinase 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase 14 | 360 aa | 336 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0152 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.5843 | 0.5843 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | hypothetical protein | 0.0013 | 0 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0152 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.6677 | 0.6677 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE CONSERVED TRANSMEMBRANE PROTEIN | 0.0013 | 0 | 0.5 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0152 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | beta-hexosaminidase B, putative | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Plasmodium vivax | LCCL domain-containing protein | 0.0013 | 0 | 0.5 |
Schistosoma mansoni | discoidin domain receptor | 0.0013 | 0 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0152 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0013 | 0 | 0.5 |
Schistosoma mansoni | dock | 0.0013 | 0 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0013 | 0 | 0.5 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0013 | 0 | 0.5 |
Loa Loa (eye worm) | TK/DDR protein kinase | 0.0094 | 0.5843 | 0.5843 |
Plasmodium vivax | LCCL domain-containing protein | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0013 | 0 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0152 | 1 | 0.5 |
Schistosoma mansoni | btb and poz domain-containing protein | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible arabinofuranosyltransferase AftD | 0.0013 | 0 | 0.5 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0152 | 1 | 0.5 |
Echinococcus granulosus | discoidin domain receptor | 0.0106 | 0.6677 | 0.6677 |
Schistosoma mansoni | discoidin domain receptor | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0152 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0152 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0152 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Schistosoma mansoni | septate junction protein | 0.0013 | 0 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0152 | 1 | 1 |
Onchocerca volvulus | 0.0108 | 0.6799 | 1 | |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0152 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0 | 0.5 |
Toxoplasma gondii | PA14 domain-containing protein | 0.0013 | 0 | 0.5 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0013 | 0 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0013 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2.17 uM | Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay | ChEMBL. | 24754677 |
Kd (binding) | = 901 nM | Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis | ChEMBL. | 22154891 |
Kd (binding) | > 1 uM | Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay | ChEMBL. | 24754677 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.